1.
Lucas CM, Harris RJ, Giannoudis A, Clark RE. c-Myc inhibition decreases CIP2A and reduces BCR-ABL1 tyrosine kinase activity in chronic myeloid leukemia. Haematologica [Internet]. 2015May5 [cited 2026Nov.14];100(5):e179-e182. Available from: https://haematologica.org/article/view/7385